Symptomatology, pathophysiology and treatment perspectives of "long COVID" syndrome
The year 2020 was marked in history by the pandemic of SARS-CoV-2 infection. The relatively quick introduction of vaccinations and antiviral drugs (e.g. orally administered molnupiravir, nirmatrelvir/ritonavir) allowed the global nature of COVID-19 to be controlled after more than 2 years. Currently...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | 図書 |
| 出版事項: |
Polish Pharmaceutical Society,
2024-04-01T00:00:00Z.
|
| 主題: | |
| オンライン･アクセス: | Connect to this object online. |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
インターネット
Connect to this object online.3rd Floor Main Library
| 請求記号: |
A1234.567 |
|---|---|
| 所蔵 1 | 利用可 |